Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease

Renske Pauwels, C.J. van der Woude, Nicole Erler, Annemarie de Vries

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
15 Downloads (Pure)
Original languageEnglish
Article number1756284820979765
JournalTherapeutic Advances in Gastroenterology
Volume13
DOIs
Publication statusPublished - 2020

Research programs

  • EMC MM-04-20-01

Cite this